Interleukin-6 (IL-6) is critical for the febrile response to peripheral immune challenge. However, the mechanism by which IL-6 enables fever is still unknown. To characterize the IL-6 dependent fever generating pathway, we used microarray analysis to identify differentially expressed genes in the brain of lipopolysaccharide (LPS)-treated IL-6 wild type and knock-out mice. Mice lacking IL-6 displayed two-times lower expression of the lipocalin-2 gene (lcn2), and this difference was confirmed by real-time RT-PCR. Conversely, induction of lipocalin-2 protein was observed in brain vascular cells following i.p. administration of recombinant IL-6, suggesting a direct relationship between IL-6 and lipocalin-2.
Introduction
Fever, which is a clinical hallmark of inflammation, is an adaptive brain-regulated host defense response that is elicited by infectious pathogens and other immune stimuli. It is generally accepted that prostaglandin E 2 (PGE 2 ) has a central role within the brain for the initiation of the neuronally regulated fever signaling (1, 2) . After an immune challenge, PGE 2 is synthesized through the induction of the enzymes cyclooxygenase-2 (Cox-2) and microsomal prostaglandin E synthase-1 (mPGES-1) and acts on neurons expressing EP 3 receptors in the thermoregulatory region of hypothalamus (2) .
Proinflammatory cytokines, like interleukin-1β (IL-1β) and interleukin-6 (IL-6), are produced and released into the bloodstream upon immune challenge and are involved in eliciting the febrile response. In particular, IL-6 is critical, because neither IL-6 knock-out (IL-6 KO) mice, nor animals treated with IL-6 antiserum develop fever upon peripheral immune stimulation (3) (4) (5) (6) . However, peripherally administrated IL-6 is by itself not or only weakly pyrogenic, at least in mice and rats (3) (4) (5) 7) . The latter observations are supported by studies showing that systemically administered IL-6, unlike IL-1β, does not trigger PGE 2 production in the brain as measured by the induction of Cox-2 (8, 9) or by the monitoring of PGE 2 in the cerebrospinal fluid (CSF) (10) , although conflicting data exist (5) .
Recent work in this laboratory has demonstrated that IL-6 KO mice, despite being afebrile upon LPS challenge, had an intact central and peripheral induction of the PGE 2 synthesizing enzymes Cox-2 and mPGES-1, and displayed similar increased concentrations of PGE 2 in the CSF as fever-mounting wild-type mice. However, when PGE 2 was administered directly into the CSF, IL-6 KO mice showed a similar dose-dependent febrile response as Hamzic et al., p. 4 wild-type (WT) mice (10, 11) . We therefore suggested that IL-6 may control some factor(s) in the inflammatory cascade, which render(s) IL-6 KO mice refractory to the pyrogenic action of PGE 2 , or that IL-6 is involved in the mechanisms that govern release of synthesized PGE 2 onto its target neurons (10) .
In the present paper, we show that a protein previously not identified to be involved in the fever generating pathway, lipocalin-2, is controlled by IL-6. We show that lipocalin-2 is induced in the brain endothelial cells upon immune stimulation, and that this induction is attenuated in the absence of IL-6, and that, conversely, IL-6 induces the expression of lipocalin-2. Furthermore, we show that, during certain conditions, absence of lipocalin-2 attenuates Cox-2 induction to lipopolysaccharide (LPS) and the concomitant febrile response.
Materials and Methods

Animals
Adult IL-6 KO mice (The Jackson Laboratory, Bar Harbor, ME), and lipocalin-2 KO mice, and their WT littermates, all on a C57B6 background, were used. Lipocalin-2 heterozygous mice were kindly provided by Dr. Jack B. Cowland, Granulocyte Research Laboratory, Copenhagen, Denmark and originally generated by Dr. Shizuo Akira, Research Institute for Microbial Diseases, Osaka University, Japan (12) . They had been backcrossed onto the C57B6 background for 10 generations before being used for the present experiments.
All animals were 9-12 weeks old at the time of experiment. They were housed one per cage in a pathogen-free facility at ambient temperature of 19-20°C, unless otherwise stated, with food and water available ad libitum, and on a 12-h light, 12-h dark cycle (lights on at 07:00). All experimental procedures were approved by the Animal Care and Use Committee at Linköping University. Hamzic et al., p. 5 LPS and IL-6 administration All injections were given to awake animals as a single dose dissolved in 100 µl saline or sterile water, administered intraperitoneally 2 h into the lights-on period (9 a.m.). LPS was from Escherichia coli (Sigma Chemical Co., St. Louis, MO; 0111:B4) and given at a dose of 120 µg/kg body weight. Murine recombinant IL-6 (Peprotech, Rocky Hill, NJ; catalog #216-16) was given at a dose of 900 ng/mouse.
RNA extraction and hybridization
The mice were asphyxiated with CO 2 3 h or 4 h after i.p. injection of LPS and rapidly perfused transcardially with saline (NaCl, 0.9 %), before samples of the hypothalamus, liver, lung, and spleen were collected. The harvested tissues were stored in RNAlater stabilizing agent (Qiagen, Hilden, Germany) at 4°C overnight and then at -20°C until further processed.
Total RNA from the hypothalamus was extracted using RNeasy Lipid Tissue Kit (Qiagen) according to the manufacturer's instructions, including deoxyribonuclease treatment with ribonuclease-free deoxyribonuclease set (Qiagen). The integrity of extracted RNA was checked by using an Agilent RNA 6000 Nano Kit and Agilent 2100 bioanalyzer (Agilent, Santa Clara, CA). The concentrations and purity of extracted RNA were measured using a NanoDrop ND-1000 Spectrophotometer (NanoDrop, Wilmington, DE).
Array protocol
A mouse GeneChip 1.0 ST array (Affymetrix, Santa Clara, CA), expressing the whole mouse genome (28,853 genes) was used. Each gene was represented by approximately 27 probes spread across the full length of the gene. In brief, double-stranded cDNA was synthesized with random hexamers tagged with a T7 promoter sequence and subsequently used as a template and amplified to produce antisense cRNA. Single stranded DNA (ssDNA) was Hamzic et al., p. 6 produced in the second cycle of cDNA synthesis, using prime reverse transcription of the cRNA. Following fragmentation and labeling, ssDNA was hybridized to the GeneChip which then was stained, washed and scanned using a Fluidics 450 station and GeneChip operating software (Affymetrix). The hybridization, washing, and scanning was performed by Bioinformatics and Expression Analysis core facility at the Karolinska Institute in Huddinge, Stockholm. The raw expression values from the array represented as CEL files were uploaded and normalized using robust multi array (RMA) as a normalization method. The differentially expressed genes satisfying the conditions of fold change cutoff 1.5 and a P-value of < 0.05 from all of the genes probed in the GeneChip were searched out with the GeneSpring GX Software (Agilent).
Real Time RT-PCR
RNA was reversely transcribed to cDNA by random hexamer priming using PrimeScript first- (1:10,000; Santa Cruz Biotechnology, Santa Cruz, CA) for 2 h at room temperature. The bands were visualized using an enhanced chemiluminescence advance western blotting detection kit (GE Healthcare). To restore and remove primary and secondary antibodies, the membrane was immersed in stripping buffer (100 Mm 2-mercaptoethanol, 2 % sodium dodecyl sulfate, 62.5 Mm Tris-Hcl; pH 6.7) for 30 min at 50°C, washed with buffer and then blocked for 30 min at room temperature. The membrane was then incubated with rabbit anti-GAPDH antibody (1:10,000; 200 µg/ml; Santa Cruz), overnight at 4°C, used here as a loading control, followed by donkey anti-rabbit HRP-conjugated secondary antibody (1:50,000; 200 µg/0.5 ml; Santa Cruz) for 1 h at room temperature after which proteins were visualized as described above.
Immunohistochemistry
Mice were asphyxiated by CO 2 3 h after i.p. injection with LPS or recombinant IL-6 and perfused with 0.9 % saline, followed by 4 % ice-cold paraformaldehyde in phosphate buffer 
Telemetric Recordings
Mice were briefly anesthetized with 1 % isoflurane (Abbot Scandinavia, Solna, Sweden), implanted i.p. with a transmitter that records core temperature (Data Science International, St.
Paul, MN), and allowed one week to recover. Body temperature recordings were started at least 1 day before immune challenge, collecting the basal temperature of each mouse to assure that it displayed normal body temperature with normal circadian variation. Baseline body temperature was calculated over an 8 hours period during the light period of the day.
Following i.p. injection with the inflammatory stimulus, data were sampled during 10 s every 2 min throughout the entire observation period.
Statistics
Microarray data as well as data on lipocalin-2 protein levels were analyzed using unpaired, two-tailed Students`t-test. Temperature data was analyzed with two-way ANOVA followed by post hoc t-test, P<0.05 was considered statistically significant. The analysis of the fever curves was divided into the different fever phases before analysis: 0-60 min (first phase) excluded due to stress response after injection; 60-220 min second phase of fever; 220-360 min third fever phase; 360-480 min recovery phase. qPCR data for each transcript and tissue were analyzed with one-way ANOVA, followed by Bonferroni post hoc test with correction for multiple comparisons. A P-value < 0.05 was considered as statistically significant. Data are expressed as mean ± SEM.
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Results
Microarray Data Analysis
The thermoregulatory center in the brain is found in the anterior part of the hypothalamus (16, 17) . In order to examine whether there was any difference in the gene expression profile after inflammatory stimuli between WT mice and IL-6 KO mice, we conducted a genome wide microarray study on mRNA extracted from the hypothalamus. Male WT mice injected intraperitoneally with LPS (120 µg/kg body weight) displayed when compared with those injected with vehicle a dramatic alteration of the expression of several genes, as reported previously (18, 19) . A total of 164 genes were altered 1.5-fold or more (P < 0.05). The majority of the genes were up regulated, and included a number of immune and acute-phase response genes and some chemokines, such as ifit1, mpa2, gbp4 and cxcl10. The top-scored up regulated and down regulated genes are listed in Table 1A .
Thus, the LPS treatment generated a robust inflammatory response as detected by the microarray system. However, when we compared the gene expression between WT and IL-6 KO mice that had been given LPS, surprisingly few genes were differentially expressed between these two genotypes (Table 1B) , despite the fact that IL-6 KO mice in contrast to the WT mice do not display a febrile response to the immune challenge (10) . The gene that displayed the largest difference in expression following LPS injection between the two genotypes was lcn2 (encoding for an acute phase protein, lipocalin-2), which was twice as abundantly expressed in WT than in IL-6 KO mice.
The other two genes that displayed significant expression differences between the two genotypes were E030010A14Rik (RIKEN cDNA E030010A14 gene), with so far no established biological function, and adamts9 (a disintegrin-like and metalloprotease domain with thrombospondin type 1 motifs 9), described to be implicated in melanoblast and limb Hamzic et al., p. 11 development (20, 21) , but that also has been suggested to function as a tumor suppressor gene in some cancers (22, 23) .
Induced expression of lipocalin-2 in brain and viscera after LPS administration in WT and IL-6 KO mice
Because of the known association of lipocalin-2 to inflammatory processes (12, 24, 25) as well as its involvement in thermogenesis (26), we next verified the results from the microarray analysis on the lcn2 gene by examining the expression of lcn2 in the hypothalamus with real-time RT-PCR 3 h after LPS injection, using the same experimental paradigm as above. The expression of lcn2 was strongly induced in WT mice upon LPStreatment, displaying over 200 times higher expression (P < 0.001) than in saline-injected mice, with no difference between sexes (Fig. 1A-B) . Notably, this difference was far larger than that seen in the microarray analysis, implying differences in the sensitivity of the two methods. While there was as strong LPS elicited induction of lcn2 also in the brains of IL-6 KO mice, it was significantly lower than in the WT mice, the difference between the genotypes being close to 3 times (P < 0.001) (Fig. 1A-B) . This difference corresponded well with the data from the microarray study that showed a fold-change of 2.06 in lcn2 expression between LPS treated WT and IL-6 KO mice (Table 1B) .
Lipocalin-2 mRNA expression levels were also examined in the liver, lung and spleen of male WT and IL-6 KO after i.p. injection of LPS. The expression of lcn2 in the liver was barely detectable in saline-injected mice, whereas it was strongly up regulated following treatment with LPS (close to 1000 times higher in LPS-treated WT mice than in saline-treated mice; P < 0.001) (Fig. 1C) . As in the brain, the induction of lcn2 in the liver was less pronounced in the LPS-treated IL-6 KO mice, the difference between the genotypes being close to two times (P < 0.05) (Fig. 1C) . In the lung and spleen, lcn2 displayed a weak Hamzic et al., p. 12 constitutive expression, which in both genotypes was moderately up regulated following treatment with LPS ( Fig. 1D-E) . Thus, in the lung, lcn2 displayed close to 10 times higher expression in LPS-treated WT mice than in saline-injected WT mice (P < 0.001), and while the LPS induced change in expression was somewhat less pronounced in the IL-6 KO mice (around 7 times), there was no statistically significant difference between the two genotypes (Fig. 1D) . In the spleen, lcn2 displayed 20 times higher expression in WT mice treated with LPS than in saline-injected WT mice (P < 0.001), and while again the up regulation by LPS was slightly lower in the IL-6 KO mice, there was again no statistically significant difference between the two genotypes (Fig. 1E ).
To confirm that the induced gene expression of lcn2 seen in the hypothalamus was reflected in differences in protein levels, the hypothalami from IL-6 KO and WT male mice, harvested 3 h after i.p. injection of LPS, were analyzed by Western blot (WB). As shown in (Fig. 2) .
Lipocalin-2 is expressed in brain vascular cells and is partly co-expressed with Cox-2 after LPS challenge
The cellular distribution of lipocalin-2 in the brain upon LPS-stimulation in IL-6 KO mice and their WT littermates was studied by immunohistochemistry 3 h after LPS injection. In control animals injected i.p. with saline, no lipocalin-2 like immunoreactivity was observed.
However, after LPS-challenge (120 µg/kg body weight), immune-positive staining for lipocalin-2 appeared in cells associated with the brain blood vessels in both IL-6 KO and WT mice (Fig. 3A) . The labeling was preferentially localized to the perinuclear regions of cells with rounded nuclei, suggesting that the labeled cells were endothelial cells. However, to positively identify the cells that expressed lipocalin-2, sections were also stained for the vWF and CD206. Dual labeling for the lipocalin-2 and vWF revealed round lipocalin-2 labeled nuclei within vWF labeled cells (Fig. 3B) , whereas dual labeling for lipocalin-2 and CD206
showed that the two markers labeled distinct cell populations (Fig. 3C) . These stainings hence identified the lipocalin-2 expressing cells as endothelial cells (13) (14) (15) .
As a final step we examined if lipocalin-2 and Cox-2 were expressed in the same cells.
As shown in Fig. 3D , the majority of brain endothelial cells stained both for lipocalin-2 and Cox-2, although single-labeled cells also were seen. Brain sections from mice that had been given saline showed only constitutive neuronal expression of Cox-2, and no labeling of either Cox-2 or lipocalin-2 in the blood vessels.
Hamzic et al., p. 14 Attenuated LPS-induced fever response in lipocalin-2 deficient females Since IL-6 is critical for LPS-induced fever, and since, as shown here, absence of IL-6 attenuates the induced expression of lipocalin-2 in brain endothelial cells, i.e. in the cells that also express the inducible PGE 2 synthesizing enzymes Cox-2 and mPGES-1 (27, 28), we next examined if lipocalin-2 was involved in fever regulation. LPS (120µg/kg b.w.) or saline was given i.p. to WT and lipocalin-2 KO mice and the temperature response was monitored either during near-thermoneutral conditions (29-30°C) or at ambient room temperature (19-20°C Intraperitoneal injection of LPS resulted in a typical triphasic fever (29, 30) with the first phase being obscured by the hyperthermia induced by handling stress associated with the injection. At an ambient temperature of 29-30°C, both genotypes displayed normal febrile response to LPS (Fig. 4A, B) , however lipocalin-2 deficient males displayed higher body temperature than WT mice at the end of the observation period (P < 0.05). When the temperature response to LPS was recorded at 19-20°C, however, a more pronounced difference between the two genotypes was seen. Thus, while lipocalin-2 KO and WT males showed almost indistinguishable temperature responses (Fig. 4C) , female lipocalin-2 KO mice displayed a significantly attenuated fever response compared with their WT littermates (Fig. 4D) , starting at approximately 4 h post LPS challenge (P < 0.05). This difference in the fever response between the genotypes was present for 70 minutes. Hamzic et al., p. 15 Cox-2 mRNA expression is lower in lipocalin-2 deficient female mice following
LPS challenge
In order to examine if the observed difference in the febrile response between lipocalin-2 KO and WT mice was due to a differential expression of Cox-2 and/or mPGES-1 in the hypothalamus, the mRNA levels of the corresponding genes were determined using real-time RT-PCR. Female lipocalin-2 KO and WT mice were injected i.p. with LPS (120 µg/kg body weight) or saline, and sacrificed 4 h later (the time point corresponding to the time point when the febrile response of the two genotypes started to differ), followed by dissection of the hypothalamus with subsequent RNA isolation and real-time RT-PCR analysis. As previously shown (10), Cox-2 and mPGES-1 mRNA were induced upon LPS stimulation (Fig. 5A-B) . A trend towards lower expression of both genes was seen in LPS-treated lipocalin-2 KO mice when compared with their WT littermates, however only for Cox-2 the difference was statistically significant (P < 0.05) (Fig. 5A) . The mRNA levels of Cox-2 in the hypothalamus were also determined in male mice devoid of lipocalin-2, using the same experimental paradigm. Cox-2 was induced in both genotypes treated with LPS, although to a lesser degree than in female mice due to higher basal mRNA expression of Cox-2 in male mice. As shown in Fig. 5C , there was no difference in Cox-2 mRNA expression between LPS-treated WT and lipocalin-2 KO male mice.
Discussion
The role of IL-6 in fever has been studied for many years, but is still elusive. While the presence of IL-6 has been shown to be necessary for the fever, IL-6 by itself seems unable to elicit a clear febrile response (3-4, 7 ). Here we demonstrate that IL-6 influences the expression in the brain of lipocalin-2, an acute phase protein that through binding to bacterial siderophores and hence preventing bacterial iron acquisition is an important component of the Hamzic et al., p. 16 innate immune response (12) . Using a genome wide microarray analysis we show that lcn2 is one of few genes in the brain that is differently expressed in IL-6 knock-out mice. We also show that IL-6 in vivo induces lipocalin-2 expression in the brain, and we demonstrate that immune challenge with LPS results in rapid and strong induction of lipocalin-2 in brain endothelial cells, being co-localized with the induced expression of the prostaglandin synthesizing enzyme Cox-2. Finally, we demonstrate that at normal ambient temperature, but not at conditions near thermoneutrality, absence of lipocalin-2 results in an attenuation of the late febrile response to LPS in female mice, and that this attenuation is associated with decreased expression of Cox-2 in brain endothelial cells. Interestingly, the late phase of the febrile response has been suggested to be elicited by mechanisms different from those that evoke the two earlier phases, because, as shown in rats, it is in contrast to the early phases attenuated by vagotomy (31) , and it is accompanied by the induction of cytosolic PLA 2 -α in the hypothalamus (32) . Our data indicate that it also may be differentially influenced by lipocalin-2, in an ambient temperature-specific and gender-dependent manner.
The results from the microarray analysis and RT-qPCR demonstrated that IL-6 was not the only factor affecting lipocalin-2 expression. In mice devoid of IL-6, a substantial upregulation of lipocalin-2 was still seen, although it only reached approximately one third of the expression level observed in WT mice. It can also be concluded from present results that the effect of lipocalin-2 on inflammatory induced fever is small, particularly considering the complete absence of LPS-induced fever in IL-6 KO mice (3, 10) . Hence, lipocalin-2 cannot be considered as a major mediator of the IL-6-dependent fever generating pathway.
Lipocalin-2 has recently attracted considerable interest, both in relation to thermogenesis and inflammation. Thus, it was shown that lipocalin-2 deficient mice were unable to maintain their body temperature when being subjected to cold stress, hence displaying an impaired adaptive thermoregulation that was suggested to be due to the Hamzic et al., p. 17 decreased mitochondrial oxidative capacity in brown adipose tissue (BAT) and skeletal muscle (26) . This is a phenotype very similar to that reported for IL-6 deficient mice, which also display significantly impaired ability to defend their core temperature during cold stress (33) , and these data hence suggest that lipocalin-2 and IL-6 may be linked in the control of thermogenesis.
Furthermore, in a model with sterile abscess, lipocalin-2 was rapidly detected at high levels in plasma and was also strongly induced in the liver (34) . In that study, similar to what was found in the present work, the lcn2 induction was abrogated in the absence of IL-6. The authors also demonstrated that IL-6 induced lcn2 in cultured hepatocytes, being in line with our in vivo demonstration of induced lipocalin-2 synthesis in the brain following IL-6 administration. These findings hence strongly support a direct relationship between IL-6 and lipocalin-2.
Only quite recently, the role of lipocalin-2 in the brain has been examined. In two studies, published after the present work had been undertaken, lipocalin-2 was shown to be induced in choroid plexus epithelial cells and in brain endothelial cells after immune challenge with LPS (24, 35) . These findings were corroborated in the present study and taken one step further by showing that lipocalin-2 co-localized with Cox-2, the rate limiting enzyme for the production of inflammatory induced PGE 2 . Lipocalin-2 also co-localized with the vWF, but not with CD206, indicating that the expression occurred exclusively in endothelial cells and not in perivascular macrophages.
The finding that the lipocalin-2 expression was influenced by IL-6, which itself is critical but not sufficient for the febrile response, and the observation that lipocalin-2 is necessary for cold induced thermogenesis, led us to examine the role of lipocalin-2 in the febrile response. While, as discussed above, lipocalin-2 KO mice displayed the same temperature elevation as WT mice in response to LPS during near-thermoneutral conditions, Hamzic et al., p. 18 female lipocalin-2 KO mice that were immune challenged at normal ambient temperature (19-20°C) displayed an attenuated febrile response which also was associated with, and hence possibly caused by, attenuated Cox-2 induction in the brain. These data indicate that lipocalin-2, and also IL-6, may influence thermogenesis at least in part by influencing Cox-2 expression. However, this issue requires further examination. While the present findings may also seem contradictory to our previous observation that Cox-2 induction (and PGE 2 levels) in the brain did not differ between IL-6 KO and WT mice (10) , it should be noted that those experiments were carried out during near-thermoneutral conditions.
The mechanism of the sex-differences in temperature response can only be speculated on. It was recently reported that lipocalin-2 KO female mice had significantly reduced levels of 17β-estradiol in serum and that estrogen receptor α was down regulated in these mice (36) , illustrating a connection between lipocalin-2 and gender specific hormones. A relationship between the levels of female gonadal hormones and Cox-2 expression and fever has been demonstrated, however in way that is opposite to the findings in the present study (37, 38) . In conclusion we have identified lipocalin-2 as a new factor in the pathway of inflammatory IL-6 signaling across the blood-brain barrier. Our data show that lipocalin-2 is induced in brain endothelial cells, known to express PGE 2 -synthesizing enzymes upon systemic immune challenge (28, 42) , and that this expression in part is under the control of IL-6. While our data also indicate that lipocalin-2 is involved in the immune-induced thermogenesis, its contribution is minor and the critical role of IL-6 for the febrile response cannot be explained by its induction of lipocalin-2. Hamzic et al., p. 28 
Figure Legends
Table 1
Differentially expressed genes (> 1.5-fold, P < 0.05) in the hypothalamus of LPS-treated WT mice (n = 7) compared with vehicle injected controls (n = 4). Genes was classified as up regulated if the expression was higher in LPS-treated WT mice than in the vehicle injected controls, and as down regulated if the expression in WT mice treated with LPS was lower than in mice that received vehicle only. Additional LPS regulated genes are listed in Table S1 .
Gene
Fold Change P-value Regulation cxcl10 29. Table 2 Differentially expressed genes (> 1.5-fold, P < 0.05) in the hypothalamus of LPS-treated WT mice (n =7) compared with IL-6 KO mice (n = 7). Data from mice 3 h after LPS treatment are
shown. Genes was classified as down regulated if the expression is lower in LPS treated IL-6 KO mice than in LPS-treated WT mice. 
